Prostate Cancer International is
for 2011 by Great NonProfits
We know from prior studies that recurrence of prostate cancer after a radical prostatectomy is related to tumor biology and to surgical surgical skill and experience, but is one more important than the other?
Filed under: Management, Treatment | Tagged: biology, experience, outcome, recurrence, skill, surgery | 5 Comments »
In this news report we summarize studies dealing with: Outcomes after RP in selected patients between 70 and 81 years of age Management of men with prostate cancer recurrence after first-line EBRT Innovative MRI-guided treatments as second- and third-line forms of management Preclinical data on MAOA inhibition in prostate cancer
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: elderly, inhibitor, MAOA, progression, PSA, radical prostatectomy, recurrence | Leave a Comment »
Some days ago we commented on a media release issued by Myriad Genetics which stated that their new PROLARIS™ test “identifies patients at low risk of disease recurrence with 95% certainty.”
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: gene test, prognosis, PROLARIS, recurrence | 5 Comments »
Myriad Genetics has announced the launch of a 46-gene prognostic test which is supposed to be able to determine the risk of prostate cancer recurrence in patients who have undergone a radical prostatectomy.
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: gene test, prognosis, PROLARIS, recurrence | 2 Comments »
D’Amico and his colleagues demonstrated some time ago that PSA velocity and PSA doubling time (PSADT) are valuable tools in predicting which patients with recurrent prostate cancer after first-line treatment are at greatest risk of metastatic disease and prostate cancer-specific mortality. But they have now shown that PSADT is less predictive of risk in men [...]
Filed under: Management, Treatment | Tagged: comorbidity, PSA doubling time, PSA velocity, PSADT, recurrence | Leave a Comment »
In today’s news reports we cover items on: Risks for prostate cancer from smoking and increased adipose tissue The role of religious activities in prostate cancer testing among African Americans Blood loss at the time of surgery and risk for progressive disease
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: adipose, blood loss, BMI, body mass index, DRE, ethnicity, recurrence, religion, risk, smoking | Leave a Comment »
A new analysis of data from the Shared Equal Access Regional Cancer Hospital (SEARCH) prostate cancer database has suggested that obese men with prostate cancer are at particularly high risk for recurrence of their disease — regardless of race.
Filed under: Living with Prostate Cancer | Tagged: obesity, recurrence, risk | Leave a Comment »
The second set of reports in today’s news commentaries encompasses new nomograms, possible new biomarkers, a specific subtype of prostate cancer, and the “hedgehog” signaling pathway.
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: biomarkers, ETS fusion, hedgehog signaling, ionized serum calcium, nomogram, recurrence, surgeon experience, survival | Leave a Comment »
Additional, non-ASTRO-related news today includes the following: Screening, treatment, and mortality in Medicare-eligible populations Genetic variants and relationships to clinical and pathological variables The application of MRI in prostate cancer management Predictors of aggressive biochemical recurrence after radical prostatectomy
Filed under: Management, Treatment | Tagged: aggressive, genetic variants, magnetic resonance, mortality, MRI, prediction, recurrence | Leave a Comment »
Search for new and
ongoing trials on the
CTAG PCa web site